Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience.

Background and Aims: Gastric varices (GV) have higher rates of morbidity and mortality from hemorrhage than esophageal varices. Several studies have shown the safety and efficacy of cyanoacrylate (CA) injection for acute gastric variceal hemorrhage. We report data from our experience with CA injecti...

Descripción completa

Detalles Bibliográficos
Publicado en:Digestive Diseases & Sciences Vol. 62; no. 11; pp. 3091 - 3100
Autores principales: Catron, Tom, Smallfield, George, Kang, Le, Sterling, Richard, Siddiqui, Mohammad, Catron, Tom D, Smallfield, George B, Sterling, Richard K, Siddiqui, Mohammad S
Formato: research tables/charts Journal Article
Publicado: Springer Nature Nov2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125824898&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 125824898
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01632116
        1VP
      jtl: Digestive Diseases & Sciences
      issn: 01632116
      maglogo: N
    pubinfo:
      dt: Nov2017
      vid: 62
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        125824898
        125824898
        144077174
        NLM28702754
        125824898
        10.1007/s10620-017-4671-2
        NLM28702754
        125824898
      ppf: 3091
      ppct: 9
      formats:
      tig:
        atl: Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience.
      aug:
        au:
          Catron, Tom
          Smallfield, George
          Kang, Le
          Sterling, Richard
          Siddiqui, Mohammad
          Catron, Tom D
          Smallfield, George B
          Sterling, Richard K
          Siddiqui, Mohammad S
        affil: Tinsley Harrison Internal Medicine Residency Training Program , University of Alabama at Birmingham , 1720 2nd Ave South Birmingham 35233 USA
      sug:
        subj:
          Gastrointestinal Hemorrhage Therapy
          Esophageal and Gastric Varices Therapy
          Hemostasis, Endoscopic Methods
          Gastrointestinal Hemorrhage
          Endoscopy, Gastrointestinal Methods
          Esophageal and Gastric Varices
          Ultrasonography, Doppler
          Recurrence
          Male
          Gastrointestinal Hemorrhage Etiology
          Kaplan-Meier Estimator
          Virginia
          Time Factors
          Predictive Value of Tests
          Endoscopy, Gastrointestinal Adverse Effects
          Esophageal and Gastric Varices Mortality
          Prognosis
          Treatment Outcomes
          Female
          Hemostasis, Endoscopic Mortality
          Esophageal and Gastric Varices Complications
          Endoscopy, Gastrointestinal Mortality
          Aged
          Risk Factors
          Middle Age
          Gastrointestinal Hemorrhage Mortality
          Hemostasis, Endoscopic Adverse Effects
          Retrospective Design
          Injections
          Human
          Aged: 65+ years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background and Aims: Gastric varices (GV) have higher rates of morbidity and mortality from hemorrhage than esophageal varices. Several studies have shown the safety and efficacy of cyanoacrylate (CA) injection for acute gastric variceal hemorrhage. We report data from our experience with CA injection for GV before and after routine use of post-injection audible Doppler assessment (ADA) for GV obturation and describe long-term outcomes after this therapy.Methods: We retrospectively identified patients who had documented GV, underwent CA injection, and had at least 2 weeks of follow-up. We recorded and analyzed the survival and rebleeding rates with patient demographics, clinical data, and endoscopy findings between two groups of patients who were categorized by CA injection prior to and after inception of the ADA technique.Results: Seventy-one patients were identified with 16 patients analyzed in a group where ADA was not used (Pre-ADA) and 55 analyzed where ADA was used (Post-ADA). No rebleeding events were observed within 1 week of initial CA injection. No embolic events were reported after any initial CA injection within 4 weeks. The rate of bleed-free survival at 1 year was 69.6% in the Pre-ADA group and 85.8% in the Post-ADA without statistical significance. The all-cause 1-year mortality was 13.8% in the Pre-ADA group and 10.7% in the Post-ADA group without statistical significance.Conclusions: ADA of CA-injected GV does not appear to significantly affect adverse events or clinical outcomes; however, our findings are limited by small sample size and cohort proportions allowing for significant type II statistical error. Further prospective investigation is required to determine the impact of ADA on clinical outcomes after GV obturation.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N